These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2789114)
1. T lymphocyte activation in systemic lupus erythematosus analysed by proliferative response to nucleoplasmic proteins on nitrocellulose immunoblots. Pham BN; Prin L; Gosset D; Hatron PY; Devulder B; Capron A; Dessaint JP Clin Exp Immunol; 1989 Aug; 77(2):168-74. PubMed ID: 2789114 [TBL] [Abstract][Full Text] [Related]
2. Defective proliferative response of T lymphocytes from patients with inactive systemic lupus erythematosus. Hernández-Fuentes MP; Reyes E; Prieto A; Zea A; Villa L; Sánchez-Atrio A; Esquivel F; Alvarez-Mon M J Rheumatol; 1999 Jul; 26(7):1518-26. PubMed ID: 10405939 [TBL] [Abstract][Full Text] [Related]
3. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052 [TBL] [Abstract][Full Text] [Related]
4. B cell activity and regulatory T cell function in systemic lupus erythematosus by human B cell colony formation. Otsuka T; Okamura S; Niho Y; Kusaba T J Rheumatol; 1985 Jun; 12(3):508-13. PubMed ID: 2864442 [TBL] [Abstract][Full Text] [Related]
5. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function. Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093 [TBL] [Abstract][Full Text] [Related]
6. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus? Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929 [TBL] [Abstract][Full Text] [Related]
7. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365 [TBL] [Abstract][Full Text] [Related]
8. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891 [TBL] [Abstract][Full Text] [Related]
10. Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus. Winfield JB; Shaw M; Minota S J Immunol; 1986 May; 136(9):3246-53. PubMed ID: 3007614 [TBL] [Abstract][Full Text] [Related]
11. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line. Minota S; Winfield JB J Immunol; 1987 Mar; 138(6):1750-6. PubMed ID: 3102598 [TBL] [Abstract][Full Text] [Related]
12. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function. Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163 [TBL] [Abstract][Full Text] [Related]
13. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study. Dhir V; Singh AP; Aggarwal A; Naik S; Misra R Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102 [TBL] [Abstract][Full Text] [Related]
14. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077 [TBL] [Abstract][Full Text] [Related]
15. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response. Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238 [TBL] [Abstract][Full Text] [Related]
16. T cell recognition of the Sm nuclear antigen: induction of T cell proliferative responses in MRL/Mp- +/+ mice. Cohen PL; Eisenberg RA J Immunol; 1982 Nov; 129(5):2142-5. PubMed ID: 6126503 [TBL] [Abstract][Full Text] [Related]
17. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus]. Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876 [TBL] [Abstract][Full Text] [Related]
18. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. Devi BS; Van Noordin S; Krausz T; Davies KA J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931 [TBL] [Abstract][Full Text] [Related]
19. Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus. Martinez-Cordero E; Alcocer-Varela J; Alarcon-Segovia D Clin Exp Immunol; 1986 Sep; 65(3):598-604. PubMed ID: 3490941 [TBL] [Abstract][Full Text] [Related]
20. Normal T cell regulation of IgG synthesis in systemic lupus erythematosus. Nies KM; Stevens RH; Louie JS J Clin Lab Immunol; 1980 Sep; 4(2):69-75. PubMed ID: 6449594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]